Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 424.61 | 559.04 | 36.88 | 3.74 |
Short Term Investments | 785.10 | 510.86 | 443.93 | 251.61 |
Cashand Short Term Investments | 1,209.70 | 1,278.10 | 563.36 | 321.08 |
Accounts Receivable- Trade Net | 215.31 | 213.67 | 180.20 | 133.63 |
Total Receivables Net | 215.31 | 223.49 | 180.36 | 133.86 |
Total Inventory | 66.85 | 64.64 | 55.52 | 41.02 |
Other Current Assets Total | 16.86 | 3.74 | 4.15 | - |
Total Current Assets | 1,508.73 | 1,579.49 | 811.72 | 502.13 |
Property/ Plant/ Equipment Total- Gross | 386.28 | 3,189.49 | 2,883.89 | 2,624.33 |
Property/ Plant/ Equipment Total- Net | 2,617.90 | 2,371.90 | 2,208.85 | 2,072.24 |
Intangibles Net | 5.54 | 5.17 | 6.27 | 7.25 |
Long Term Investments | 27.23 | 42.99 | 20.00 | 27.03 |
Note Receivable- Long Term | 66.04 | 89.97 | 69.69 | 59.39 |
Other Long Term Assets Total | 78.64 | 26.46 | 28.99 | 26.06 |
Total Assets | 4,304.08 | 4,115.96 | 3,145.52 | 2,694.11 |
Accounts Payable | 186.78 | 194.69 | 134.33 | 131.55 |
Current Portof LT Debt/ Capital Leases | 171.89 | 139.36 | 105.59 | 102.95 |
Other Currentliabilities Total | 259.07 | 175.70 | 104.00 | 105.55 |
Total Current Liabilities | 617.73 | 572.55 | 419.48 | 404.66 |
Long Term Debt | 283.47 | 737.12 | 767.63 | 577.70 |
Capital Lease Obligations | 346.52 | 245.48 | 235.70 | 250.72 |
Total Long Term Debt | 629.98 | 982.59 | 1,003.33 | 828.42 |
Total Debt | 801.87 | 1,121.95 | 1,108.93 | 931.38 |
Deferred Income Tax | 24.16 | 18.81 | 0.00 | 0.00 |
Minority Interest | -0.03 | - | - | - |
Other Liabilities Total | 126.61 | 113.80 | 106.70 | 78.68 |
Total Liabilities | 1,398.45 | 1,687.76 | 1,529.51 | 1,311.76 |
Common Stock Total | 53.70 | 53.64 | 50.65 | 49.59 |
Retained Earnings( Accumulated Deficit) | 2,851.93 | 1,307.52 | 980.41 | 813.23 |
Total Equity | 2,905.63 | 2,428.21 | 1,616.01 | 1,382.34 |
Total Liabilities Shareholders' Equity | 4,304.08 | 4,115.96 | 3,145.52 | 2,694.11 |
Total Common Shares Outstanding | 26.85 | 26.82 | 26.82 | 26.82 |
Tangible Book Valueper Share Common Eq | 108.02 | 90.35 | 60.02 | 50.06 |
Cash | - | 208.20 | 82.55 | 65.73 |
Prepaid Expenses | - | 9.52 | 8.33 | 6.18 |
Accumulated Depreciation Total | - | -817.60 | -675.05 | -552.09 |
Accrued Expenses | - | 62.80 | 75.56 | 64.61 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 1,067.05 | 584.96 | 487.02 |
Preferred Stock- Non Redeemable Net | - | - | 0.00 | 325.00 |
Global Health Dividend Global Health Bonus Global Health News Global Health AGM Global Health Rights Global Health Splits Global Health Board Meetings Global Health Key Metrics Global Health Shareholdings Global Health Profit Loss Global Health Cashflow Global Health Q1 Results Global Health Q2 Results Global Health Q3 Results Global Health Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks